Table 1.

Summary of available studies reporting on gemcitabine in the treatment of chondrosarcomas (all histotypes)

	Type of study	Regimen	Patients (n)	Best response (RECIST)
Merimsky et al., 2000 [25]	Prospective	Gemcitabine alone	3	2 SD, 1 PD
Fox et al., 2012 [8]	Prospective	Gemcitabine/docetaxel	25	2 PR, 14 SD, 9 PD
Italiano et al., 2013 [7]	Retrospective	Gemcitabine-based combinations	n/a	3 PR

Legend. RECIST: response evaluation criteria in solid tumour; SD: stable disease; PD: progressive disease; PR: partial response; n/a: not available.